Allergen Standardization
Research activity centers on the biological standardization of allergenic extracts used in the assessment and treatment of respiratory allergy, with particular attention to plant- and mite-derived materials.
- Olea europaea allergen extract
- Dermatophagoides pteronyssinus extract
- Blomia tropicalis extract
- Lepidoglyphus destructor extract
These activities reflect a strong focus on defining and characterizing allergen sources relevant to IgE-mediated sensitisation.
House Dust Mite Allergy
The sponsor is actively involved in clinical research on allergic rhinitis and rhinoconjunctivitis caused by dust mite allergy, with emphasis on diagnostic and therapeutic applications of standardized mite extracts.
- Dermatophagoides pteronyssinus
- Dermatophagoides farinae
- IgE-mediated sensitisation
Work in this area supports the clinical use of mite allergens in both allergy diagnosis and immunotherapy for respiratory disease.
Grass Pollen Allergy
Another key area of interest is allergic rhinitis and rhinoconjunctivitis linked to grass pollen allergy, especially with extracts derived from Phleum pratense.
- Phleum pratense allergen extract
- Subcutaneous and sublingual immunotherapy
- Respiratory allergy
The research portfolio includes evaluation of allergen extracts relevant to seasonal pollen sensitization and treatment planning.
Allergen Immunotherapy
The sponsor funds studies focused on sublingual immunotherapy for respiratory allergies, including standardized mixtures and single allergen extracts intended for clinical use in patients with pollen and mite sensitization.
- Dermatophagoides allergen mixtures
- Phleum pratense immunotherapeutic use
- Safety in allergy treatment
These trials address therapeutic options for allergies with a focus on extract-based treatment strategies.
